# OpenAI Researcher Miles Wang Launching $2B Drug Discovery Startup

> Miles Wang, an OpenAI researcher focused on AI-accelerated scientific discovery, is in talks to leave and launch his own drug discovery startup at a reported 2 billion dollar valuation, with several other OpenAI researchers expected to follow him out the door. It is a striking number for a company that, by these accounts, barely exists yet. The move fits a clear pattern. Researchers who built frontier models inside the big labs are peeling off to apply that expertise to specific, high-value scientific domains, and biotech is the favorite target. Investors are willing to fund them at eye-watering valuations on reputation alone, betting that model-building talent transfers directly into discovering medicines. The talent flow is worth watching as much as the science. Every senior researcher who leaves carries hard-won knowledge about training and scaling models, and a wave of well-funded spinouts spreads that capability across the industry. For OpenAI it is a retention problem, but for the field it may be how frontier techniques finally reach drug discovery at scale.

_Section: [Daily AI Updates](https://www.wortins.com/daily-ai) · Source: TechCrunch · Published Wednesday, July 15, 2026_

## Wortins' read

Miles Wang, an OpenAI researcher focused on AI-accelerated scientific discovery, is in talks to leave and launch his own drug discovery startup at a reported 2 billion dollar valuation, with several other OpenAI researchers expected to follow him out the door. It is a striking number for a company that, by these accounts, barely exists yet. The move fits a clear pattern. Researchers who built frontier models inside the big labs are peeling off to apply that expertise to specific, high-value scientific domains, and biotech is the favorite target. Investors are willing to fund them at eye-watering valuations on reputation alone, betting that model-building talent transfers directly into discovering medicines. The talent flow is worth watching as much as the science. Every senior researcher who leaves carries hard-won knowledge about training and scaling models, and a wave of well-funded spinouts spreads that capability across the industry. For OpenAI it is a retention problem, but for the field it may be how frontier techniques finally reach drug discovery at scale.

## Source

[Read the full story at TechCrunch](https://techcrunch.com/2026/07/14/openai-researcher-miles-wang-in-talks-to-launch-ai-drug-discovery-startup-valued-at-2b/)

## Related coverage

- [Apple sues OpenAI alleging trade secret theft and coordinated misconduct](https://www.wortins.com/story/apple-sues-openai-alleging-trade-secret-theft-and-coordinate-b42538c6) — [Silicon Republic](https://www.siliconrepublic.com/business/apple-sues-openai-over-alleged-trade-secrets-theft)
- [Big-5 hyperscalers committing $725B to AI infrastructure capex in 2026, reshaping market](https://www.wortins.com/story/big-5-hyperscalers-committing-725b-to-ai-infrastructure-cape-cbc8f42b) — [Futurum Research](https://futurumgroup.com/insights/ai-capex-2026-the-690b-infrastructure-sprint/)
- [NVIDIA and ServiceNow Launch Project Arc: Persistent Autonomous Desktop Agent](https://www.wortins.com/story/nvidia-and-servicenow-launch-project-arc-persistent-autonomo-8e9f78ab) — [servicenow.com](https://newsroom.servicenow.com/press-releases/details/2026/ServiceNow-extends-agentic-AI-governance-from-desktops-to-data-centers-with-NVIDIA/default.aspx)
- [Google Gemini 3.5 Pro targets July 17 launch after architectural rebuild](https://www.wortins.com/story/google-gemini-3-5-pro-targets-july-17-launch-after-architect-a33376a4) — [TechTimes](https://www.techtimes.com/articles/320308/20260713/gemini-35-pro-targets-july-17-after-full-rebuild-every-spec-remains-unconfirmed.htm)
- [Europe faces AI talent exodus to US but emerging 'brain regain' momentum counters trend](https://www.wortins.com/story/europe-faces-ai-talent-exodus-to-us-but-emerging-brain-regai-7bddcc1e) — [Euronews](https://www.euronews.com/my-europe/2026/01/29/the-brain-drain-why-europe-cant-keep-the-talent-it-trains)
- [Etched emerges with $800M in funding and $1B in signed inference chip contracts](https://www.wortins.com/story/etched-emerges-with-800m-in-funding-and-1b-in-signed-inferen-8495fef5) — [TechCrunch](https://techcrunch.com/2026/06/30/nvidia-competitor-etched-hits-5b-valuation-1b-in-sales-for-ai-chip/)

---

_Curated and written by [Wortins](https://www.wortins.com) — The daily AI briefing. Every story links to its original source; the "Wortins read" on each is our own original analysis. [About Wortins & our editorial approach](https://www.wortins.com/about)._